Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by French National Agency for Research on AIDS and Viral Hepatitis.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Gilead Sciences
Roche Pharma AG
Information provided by (Responsible Party):
French National Agency for Research on AIDS and Viral Hepatitis
ClinicalTrials.gov Identifier:
NCT00391638
First received: October 23, 2006
Last updated: February 21, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2012
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)